实时全球研报
First Read Altria Group Inc Off the 2Q26 conference call
研报英文原文证据摘录
First Read Altria Group Inc Off the 2Q26 conference call
Forecast returns
Forecast price appreciation 5.4%
Forecast dividend yield 5.9%
Forecast stock return 11.3%
Market return assumption 9.3%
Forecast excess return 2.1%
Company Description
Altria Group is a leading listed US tobacco/nicotine company with a domestic-focused
portfolio, including Marlboro (cigarettes), Copenhagen (smokeless tobacco), on! (nicotine
pouches), and NJOY (e-vapor). Altria has a JV, Horizon, to commercialize Ploom heated
tobacco products. In 2025, the group recorded net revenue of $20.1bn and adjusted
operating income of $12.3bn. Its targets to 2028 include a mid-single-digit adjusted EPS
CAGR from a $4.87 base in 2022, mid-single-digit dividend-per-share growth, and an
adjusted OCI margin of at least 60%. Also, Altria owns a c8% stake in ABI.
Valuation Method and Risk Statement
We use a multiples based approach to set our target prices for the tobacco companies, with
reference to factors such as volume change, organic sales growth, organisational change,
tobacco transformation, balance sheet leverage and (comparative) valuation. For MO, our
target price is based on a P/E multiple of 12.4x, applied to our FY27 EPS estimate, rolled
forward.
Company-specific risks for MO include: (a) General consumer preferences and/or government
regulation pertaining to the consumption of Tobacco or Tobacco-related products (including
taxation, restrictions on sales, the introduction or subsidisation of substitute products,
labelling requirements, etc.); (b) Government regulation with respect to commerce and/or
taxation in general; (c) Macroeconomic trends, interest rate, and/or credit environments
within any of our companies' key markets; (d) Competitive intensity between Tobacco
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器